SUGP1 loss drives SF3B1 hotspot mutant missplicing in cancer

Peiqi Xing1, Pedro Bak-Gordon2, Jindou Xie3

  • 1National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China; Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.

Cell Reports
|July 27, 2025
PubMed

Insights

Mutations in SF3B1 splicing factor cause cancer missplicing. Loss of SUGP1 protein fully mimics these defects, while loss of Aquarius (AQR) has an indirect effect, highlighting SUGP1's crucial role.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The splicing factor SF3B1 is frequently mutated in cancer, leading to aberrant 3' splice site usage and missplicing.
  • The precise molecular mechanisms underlying SF3B1 mutation-induced splicing dysregulation remain incompletely understood.

Purpose of the Study:

  • To computationally identify proteins whose reduced expression phenocopies splicing defects caused by oncogenic SF3B1 mutations.
  • To elucidate the mechanistic link between SF3B1 mutations and splicing alterations.

Main Methods:

  • A computational screen of 600 splicing-related proteins was performed.
  • Knockdown and knockout strategies were used to assess the functional impact of protein loss on splicing.
  • Comparison of splicing defects induced by SF3B1 mutations with those caused by the loss of other splicing factors.

Main Results:

  • The study identified two proteins whose loss recapitulates SF3B1 mutation-associated splicing defects.
  • Loss of the G-patch protein SUGP1 phenocopied nearly all splicing defects observed with SF3B1 hotspot mutations.
  • Loss of the RNA helicase Aquarius (AQR) reproduced approximately 40% of these defects, but indirectly through SUGP1 missplicing.

Conclusions:

  • SUGP1 plays a fundamental and direct role in mediating splicing defects caused by oncogenic SF3B1 mutations.
  • AQR contributes indirectly to SF3B1-associated splicing defects, primarily by influencing SUGP1 levels and splicing.
  • This research deepens the understanding of cancer-related missplicing and identifies key regulatory players.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K